Form 4 Novocure Ltd For: Apr 23 Filed by: Palti Yoram
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
NovoCure Ltd. (NVCR) PT Raised to $31 at Deutsche Bank
April 27, 2018 7:46 AM EDTDeutsche Bank raised its price target on NovoCure Ltd. (NASDAQ: NVCR) to $31.00 (from $29.00) while maintaining a Buy rating.
Analyst Gregg Gilbert commented, "NVCR reported strong patient uptake in GBM globally, with US contributing a majority of the increase in patient numbers... More
